rs6075193
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002594.5(PCSK2):c.283-18915T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.392 in 151,998 control chromosomes in the GnomAD database, including 12,836 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.39 ( 12836 hom., cov: 32)
Consequence
PCSK2
NM_002594.5 intron
NM_002594.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.458
Genes affected
PCSK2 (HGNC:8744): (proprotein convertase subtilisin/kexin type 2) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The protein undergoes an initial autocatalytic processing event and interacts with a neuroendocrine secretory protein in the ER, exits the ER and sorts to secretory granules, where it is cleaved and catalytically activated during intracellular transport. The encoded protease is packaged into and activated in dense core secretory granules and expressed in the neuroendocrine system and brain. This gene encodes one of the seven basic amino acid-specific members which cleave their substrates at single or paired basic residues. It functions in the proteolytic activation of polypeptide hormones and neuropeptides precursors. Single nucleotide polymorphisms in this gene may increase susceptibility to myocardial infarction and type 2 diabetes. This gene may also play a role in tumor development and progression. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.558 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCSK2 | NM_002594.5 | c.283-18915T>C | intron_variant | Intron 2 of 11 | ENST00000262545.7 | NP_002585.2 | ||
PCSK2 | NM_001201528.2 | c.226-18915T>C | intron_variant | Intron 3 of 12 | NP_001188457.1 | |||
PCSK2 | NM_001201529.3 | c.178-18915T>C | intron_variant | Intron 1 of 10 | NP_001188458.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCSK2 | ENST00000262545.7 | c.283-18915T>C | intron_variant | Intron 2 of 11 | 1 | NM_002594.5 | ENSP00000262545.2 | |||
PCSK2 | ENST00000377899.5 | c.226-18915T>C | intron_variant | Intron 3 of 12 | 1 | ENSP00000367131.1 | ||||
PCSK2 | ENST00000536609.1 | c.178-18915T>C | intron_variant | Intron 1 of 10 | 2 | ENSP00000437458.1 | ||||
PCSK2 | ENST00000470007.1 | n.278-18915T>C | intron_variant | Intron 2 of 5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.392 AC: 59501AN: 151880Hom.: 12816 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
59501
AN:
151880
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.392 AC: 59559AN: 151998Hom.: 12836 Cov.: 32 AF XY: 0.385 AC XY: 28628AN XY: 74310 show subpopulations
GnomAD4 genome
AF:
AC:
59559
AN:
151998
Hom.:
Cov.:
32
AF XY:
AC XY:
28628
AN XY:
74310
Gnomad4 AFR
AF:
AC:
0.563635
AN:
0.563635
Gnomad4 AMR
AF:
AC:
0.287489
AN:
0.287489
Gnomad4 ASJ
AF:
AC:
0.30554
AN:
0.30554
Gnomad4 EAS
AF:
AC:
0.0299459
AN:
0.0299459
Gnomad4 SAS
AF:
AC:
0.279601
AN:
0.279601
Gnomad4 FIN
AF:
AC:
0.330619
AN:
0.330619
Gnomad4 NFE
AF:
AC:
0.358524
AN:
0.358524
Gnomad4 OTH
AF:
AC:
0.37358
AN:
0.37358
Heterozygous variant carriers
0
1724
3447
5171
6894
8618
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
544
1088
1632
2176
2720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
725
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at